Cargando…
Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
Duloxetine is a serotonin-norepinephrine reuptake inhibitor approved by the US Food and Drug Administration for the treatment of fibromyalgia and painful diabetic neuropathy at doses of 60 mg daily. Duloxetine has been shown to significantly improve the symptoms of chronic pain associated with these...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048581/ https://www.ncbi.nlm.nih.gov/pubmed/21386950 http://dx.doi.org/10.2147/JPR.S12866 |